Hypera S.A.'s latest marketcap:
As of 07/29/2025, Hypera S.A.'s market capitalization has reached $2.93 B. According to our data, Hypera S.A. is the 4911th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
Market Cap | $2.93 B |
Revenue (ttm) | $1.2 B |
Net Income (ttm) | $145.23 M |
Shares Out | 631.8 M |
EPS (ttm) | $0.23 |
Forward PE | 9.55 |
Ex-Dividend Date | 06/27/2025 |
Earnings Date | 08/07/2025 |
Hypera S.A.'s yearly market capitalization.
Date | Market Cap(R$) | Market Cap(USD) | Change (%) | Global Rank |
---|---|---|---|---|
07/29/2025 | R$16.34 B | $2.93 B | 44.96% | 4911 |
12/30/2024 | R$11.45 B | $1.84 B | -49.4% | 6006 |
12/28/2023 | R$22.62 B | $4.65 B | -20.96% | 3030 |
12/29/2022 | R$28.61 B | $5.39 B | 60.1% | 2537 |
12/30/2021 | R$17.87 B | $3.19 B | -17.59% | 4515 |
12/30/2020 | R$21.69 B | $4.16 B | -3.61% | 3279 |
12/30/2019 | R$22.5 B | $5.59 B | 17.88% | 2194 |
12/28/2018 | R$19.09 B | $4.92 B | -16.12% | 2051 |
12/28/2017 | R$22.76 B | $6.86 B | 38.24% | 1828 |
12/29/2016 | R$16.46 B | $5.05 B | 19.93% | 1921 |
Company Profile
About Hypera S.A.
Hypera S.A. is a leading pharmaceutical company based in Brazil, specializing in prescription drugs, over-the-counter medications, skincare products, and nutritional supplements. Formerly known as Hypermarcas S.A., the company rebranded to Hypera S.A. in February 2018.
Product Portfolio
Prescription Pharmaceuticals: The company offers a wide range of prescription medications under brands such as:
- Adacne, Addera, apri, AmpliumG
- Celestamine, Celestone, Diprosone, diprospan
- Emprol XR, Garasone, Halobex, Lipanon
- Nesina, Novotram, PredSim, Quadriderm
Skincare & Over-the-Counter Products: Hypera provides sun protection, moisturizers, and OTC drugs under brands like:
- Mantecorp Skincare, Doralgina, Benegrip, Buscopan
- Engov, Epocler, Neosaldina, Neo Química
Nutritional & Vitamin Supplements: The company also offers supplements under:
- Tamarine, Biotônico Fontoura, Zero-Cal
Generic Medicines: Hypera supplies affordable generic alternatives, including:
- Hydroxyzine, Ibuprofen, Losartan Potassium, Omeprazole
- Paracetamol, Tadalafil, Desogestrel
Company Background
Founded in 1999, Hypera S.A. is headquartered in São Paulo, Brazil, and continues to expand its presence in the pharmaceutical and healthcare industry.
Frequently Asked Questions
-
What is Hypera S.A.'s (BVMF-HYPE3) current market cap?As of 07/29/2025, Hypera S.A. (including the parent company, if applicable) has an estimated market capitalization of $2.93 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Hypera S.A. (BVMF-HYPE3) rank globally by market cap?Hypera S.A. global market capitalization ranking is approximately 4911 as of 07/29/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.